Keyphrases
Oncogenic Kras
100%
Metastatic Pancreatic Ductal Adenocarcinoma
100%
Mammalian Target of Rapamycin Signaling
100%
Mammalian Target of Rapamycin (mTOR)
100%
Pancreatic Ductal Adenocarcinoma
50%
ALDH1A3
50%
Tuberous Sclerosis Complex
33%
Downstream Targets
33%
TSC1
33%
Haploinsufficiency
16%
Multi-target
16%
Mouse Tumor
16%
Transcriptional Profiling
16%
Dual Inhibition
16%
Phosphoinositide 3-kinase (PI3K)
16%
Cell Apoptosis
16%
Antitumor Activity
16%
Therapeutic Response
16%
MTOR Inhibitor
16%
Transgenic Mouse Model
16%
Oncogenic Activity
16%
Oncogenic Signaling
16%
Primary Cancer Cells
16%
Aggressive Subtypes
16%
Feedback Activation
16%
Pten
16%
Pathway Alteration
16%
Human Material
16%
Medicine and Dentistry
Carcinogenesis
100%
Pancreas Adenocarcinoma
100%
Mechanistic Target of Rapamycin
100%
Cancer Cell
25%
Pancreatic Ductal Adenocarcinoma
25%
Tuberous Sclerosis
25%
Biological Marker
12%
In Vitro
12%
Transgenic Mouse
12%
Haploinsufficiency
12%
Programmed Cell Death
12%
Antineoplastic Activity
12%
Treatment Response
12%
Gene Expression Profiling
12%
Primary Tumor
12%
Mammalian Target of Rapamycin Inhibitor
12%
Tumor
12%
Protein Kinase B
12%
Oncogenic activity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Carcinogenesis
100%
Mammalian Target of Rapamycin
100%
Tuberous Sclerosis
25%
Mouse Model
12%
Transgenic Mouse
12%
Antitumor Activity
12%
Malignant Neoplasm
12%
Biological Marker
12%
Mammalian Target of Rapamycin Inhibitor
12%
Primary Tumor
12%
Oncogenic activity
12%